ANEB
Anebulo Pharmaceuticals (ANEB)
$99
About Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Details
Daily high
$1.27
Daily low
$0.80
Price at open
$1.17
52 Week High
$3.30
52 Week Low
$0.80
Market cap
25.7M
Dividend yield
0.00%
Volume
88,120
Avg. volume
19,499
P/E ratio
-3.23
Anebulo Pharmaceuticals News
Details
Daily high
$1.27
Daily low
$0.80
Price at open
$1.17
52 Week High
$3.30
52 Week Low
$0.80
Market cap
25.7M
Dividend yield
0.00%
Volume
88,120
Avg. volume
19,499
P/E ratio
-3.23